Treatment of Recurrent Acute CPP Crystal Arthritis with Three or More Attacks
Patients with calcium pyrophosphate deposition (CPPD) disease who experience repeated flares of acute CPP crystal arthritis — particularly those with three or more documented attacks — require a preventive management strategy focused on reducing ongoing flare burden.
Clinical scenario: Recurrent acute CPP crystal arthritis with three or more attacks. When flares become this frequent, current guidance moves beyond episodic treatment toward a regular prophylactic approach to reduce attack frequency.
Approach: Evidence supports the use of an oral prophylactic agent taken on a scheduled basis. The complete regimen — including agent selection, dosing considerations, and tolerability adjustments — is detailed in the full structured protocol.
Treatment goal: Reduction in the number of acute CPP crystal arthritis flares.
References
DOI: 10.3389/fmed.2024.1327715
- For patients who experience three or more attacks, it is suggested to take colchicine (0.5 or 0.6 mg twice daily) as a prophylaxis.
- Some patients may find it more tolerable to reduce the dose to 0.5 or 0.6 mg once daily or every other day, although there is no evidence to support the reduction of flares with lower doses.
- Studies have shown that oral colchicine may be effective in reducing the number of flares in CPPD patients.
View source ↗